Vagus nerve stimulation in the treatment of epilepsy

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 10, 2004, Pages 1165-1166

  Guberman, Alan ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; EPILEPSY; HUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; RISK ASSESSMENT; SHORT SURVEY; TREATMENT INDICATION; VAGUS NERVE STIMULATION;

EID: 8744253321     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1041039     Document Type: Short Survey

References (6)

1. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002;59(Suppl 4):S3-S14.
2. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology 1995;45:224-30.
3. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51(1):48-55.
4. DeGiorgio CM, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsie 2000;41(9):1195-200.
5. Wheless JW, Maggio V. Vagus nerve stimulation therapy in patients younger than 18 years. Neurology 2002;59(6Suppl 4):S21-S25.
6. Schachter SC. Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 2002;59(6 Suppl 4):S15-S20.